Suppressor of T-cell receptor signaling proteins (Sts proteins)

Suppressor of T-cell receptor signaling (Sts) proteins, comprising Sts-1 (UBASH3B) and Sts-2 (UBASH3A), are critical negative regulators of signaling pathways in hematopoietic cells, particularly T lymphocytes [3, 5]. These proteins are characterized by a unique domain architecture that includes a ubiquitin-associated (UBA) domain, an SH3 domain, and a C-terminal histidine phosphatase domain [1, 6]. Sts-1 possesses potent protein tyrosine phosphatase activity and targets key signaling molecules such as Zap-70 and Syk for dephosphorylation, thereby dampening T-cell activation and platelet signaling [4, 5]. In oncology, Sts-1 is often overexpressed and acts as an oncogene by stabilizing receptor tyrosine kinases like the epidermal growth factor receptor (EGFR) and promoting leukemogenesis in acute myeloid leukemia [1, 2]. Conversely, genetic variants of Sts-2 are strongly associated with susceptibility to various autoimmune diseases, including type 1 diabetes and systemic lupus erythematosus [7, 8]. Therapeutic targeting of Sts proteins, particularly with small molecule inhibitors like rebamipide, is being explored to enhance anti-tumor immunity or treat specific malignancies, though potential risks include the induction of autoimmunity or prothrombotic states [1, 5, 18].

Other names

Suppressor of T-cell signaling proteinsUBASH3 familyT-cell ubiquitin ligand proteinsTULA proteinsUbiquitin-associated and SH3 domain-containing proteins

Inhibition of histidine phosphatase activity